Chemeca Drugs Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CLOPIDOGREL BISULFATE USP, with a corresponding US DMF Number 33710.
Remarkably, this DMF maintains an Active status since its submission on February 05, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 30, 2021, and payment made on February 04, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II